# Urinary Bladder cancer trials, no drug phase: 87 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 87 trials with no drug phase for Urinary Bladder cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Urinary Bladder cancer trials with no drug phase: 87 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/urinary-bladder-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 87
- Recruiting or not yet: 87
- Read on: November 19, 2026

## Trials

The 25 newest of 87, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07928154 | MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment | Barbara Ann Karmanos Cancer Institute | Not applicable | Not yet recruiting | Breast Cancer, Gastrointestinal Cancer, Lung Cancer (Diagnosis), Prostate Cancer (Diagnosis), Head and Neck Cancer... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928154) |
| November 9, 2026 | NCT07924046 | Diagnostic Performance of Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Bladder Tumour for Prediction of... | University of Lausanne Hospitals | Not applicable | Not yet recruiting | Urinary Bladder Cancer, NMIBC, TURBT, Vi-Rads | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924046) |
| November 3, 2026 | NCT07912034 | EHR Integrated Remote Patient Monitoring to Reduce Readmission for Patients With Bladder Cancer Undergoing Cystectomy | University of Michigan Rogel Cancer Center | Not applicable | Recruiting | Bladder Carcinoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912034) |
| November 2, 2026 | NCT07908407 | Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial | Fred Hutchinson Cancer Center | Not applicable | Not yet recruiting | Bladder Carcinoma, Prostate Carcinoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908407) |
| October 30, 2026 | NCT07907575 | The Role of ERBT Plus Adjuvant Intravesical Induction and Maintenance Chemotherapy for Intermediate-Risk NMIBC | Chinese University of Hong Kong | Not applicable | Not yet recruiting | Bladder Cancer | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907575) |
| October 14, 2026 | NCT07873333 | The Role of Definitive Radiotherapy in Non Muscle Invasive Bladder Cancer | Assiut University | Not applicable | Not yet recruiting | Non Muscle Invasive Bladder Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873333) |
| September 14, 2026 | NCT07817173 | Feasibility of HISA During TURBT for NMIBC | CAMC Health System | Not applicable | Not yet recruiting | Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Non-muscle Invasive Bladder... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817173) |
| August 13, 2026 | NCT07762820 | REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors | Ludwig-Maximilians - University of Munich | Not applicable | Not yet recruiting | Bladder Cancer, Bladder Cancer TNM Staging Primary Tumor (T) T1 | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762820) |
| August 6, 2026 | NCT07749924 | Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC | Tianjin Medical University Second Hospital | Not applicable | Recruiting | Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC) | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749924) |
| July 27, 2026 | NCT07728474 | LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder | LifeBiotic Medical Research Ltd. | Not applicable | Recruiting | Non-muscle Invasive Bladder Cancer (NMIBC) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728474) |
| July 27, 2026 | NCT07727343 | AI-Guided TURBT for Bladder Cancer | Fudan University | Not applicable | Not yet recruiting | Bladder Cancer | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07727343) |
| July 24, 2026 | NCT07724886 | Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC | Chinese University of Hong Kong | Not applicable | Recruiting | Bladder Cancer | 732 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07724886) |
| June 15, 2026 | NCT07646847 | A Study of a Side Effects and Resource Navigation Program for People With Cancer | Memorial Sloan Kettering Cancer Center | Not applicable | Recruiting | Kidney Cancer, Bladder Cancer, Breast Cancer, Lung Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646847) |
| June 10, 2026 | NCT07638410 | Prehabilitation in High-risk Oncologic Surgery | Fox Chase Cancer Center | Not applicable | Recruiting | Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer, Esophageal Cancer, Bladder Cancer, Ovarian Cancer, Abdominal... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638410) |
| April 29, 2026 | NCT07555756 | An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models | First Affiliated Hospital of Guangxi Medical University | Not applicable | Not yet recruiting | Kidney Calculi, Prostatic Hyperplasia, Urinary Bladder Neoplasms | 1,080 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555756) |
| April 23, 2026 | NCT07548476 | Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy | Dana-Farber Cancer Institute | Not applicable | Recruiting | Metastatic Bladder Cancer, Peripheral Neuropathy, Advanced Urothelial Cancer, Metastatic Urothelial Cancer, Bladder... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07548476) |
| April 13, 2026 | NCT07524426 | Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment | Umeå University | Not applicable | Recruiting | Bladder Cancer (BC) | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524426) |
| March 27, 2026 | NCT07495072 | Early vs Delayed Intravesical Blad-Care During BCG Therapy | BLAD-HYA Group | Not applicable | Recruiting | Urinary Bladder Neoplasms, BCG-Induced Cystitis | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495072) |
| March 11, 2026 | NCT07463963 | Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract... | Poitiers University Hospital | Not applicable | Recruiting | Bladder Cancer, Transurethral Resection of the Bladder, Urinary Tract Infection Bacterial | 2,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463963) |
| February 17, 2026 | NCT07413523 | Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by... | Istituto Clinico Humanitas | Not applicable | Recruiting | Bladder Cancer, Urothelial Carcinoma (UC), Oligometastasis | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07413523) |
| February 13, 2026 | NCT07408830 | VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors | VA Office of Research and Development | Not applicable | Not yet recruiting | High-Grade Early-Stage Bladder Cancer | 2,482 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408830) |
| February 11, 2026 | NCT07403630 | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC... | Azienda Ospedaliero-Universitaria di Parma | Not applicable | Recruiting | Acute Leukemia, Multiple Myeloma, Squamous Cell Carcinoma, Pleural Mesothelioma, Pancreatic Cancer, Bladder Cancer... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07403630) |
| January 14, 2026 | NCT07339761 | Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study | University of Aarhus | Not applicable | Recruiting | Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC), Muscle-Invasive Bladder Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07339761) |
| January 7, 2026 | NCT07324798 | Adaptive Radiotherapy for Genitourinary Cancers | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not applicable | Recruiting | Prostate Cancer (Post Prostatectomy), Bladder Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07324798) |
| December 24, 2025 | NCT07302230 | Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With... | University of Washington | Not applicable | Recruiting | Localized Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07302230) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Chinese University of Hong Kong | 5 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Western University, Canada | 2 |
| University of Washington | 2 |
| Zhujiang Hospital | 2 |
| National Taiwan University Hospital | 2 |
| Tianjin Medical University Second Hospital | 2 |
| Johns Hopkins University | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Assiut University | 2 |
| Brigham and Women's Hospital | 2 |
| Hospices Civils de Lyon | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| University of Colorado, Denver | 1 |
| Qilu Hospital of Shandong University | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| Pacific Edge Limited | 1 |
| Umeå University | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 1 |
| Amsterdam UMC | 1 |
| LifeBiotic Medical Research Ltd. | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
| University of Chicago | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 30 |
| China | 14 |
| France | 6 |
| Italy | 5 |
| Hong Kong | 4 |
| Netherlands | 4 |
| Canada | 3 |
| Denmark | 3 |
| Germany | 3 |
| South Korea | 3 |
| Turkey (Türkiye) | 2 |
| Taiwan | 2 |
| United Kingdom | 2 |
| Sweden | 1 |
| Israel | 1 |
| Greenland | 1 |
| Slovakia | 1 |
| Egypt | 1 |
| Belgium | 1 |
| Poland | 1 |
| Switzerland | 1 |
| Vietnam | 1 |
| Brazil | 1 |
| Finland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Hydro jetting companies in the United States](https://specstream.ai/data/businesses/hydro-jetting-companies/united-states)
- [Family practice clinics in the United States](https://specstream.ai/data/businesses/family-practice-clinics/united-states)
- [Concierge medicine practices in the United States](https://specstream.ai/data/businesses/concierge-medicine-practices/united-states)
- [Bankruptcy law firms in the United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/united-states)
- [Window installers in the United States](https://specstream.ai/data/businesses/window-installers/united-states)
- [Steakhouses in the United States](https://specstream.ai/data/businesses/steakhouses/united-states)
